| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |